Ex Vivo Enzymatic Treatment Converts Blood Type A Donor Lungs into Universal Blood Type Lungs

Investigators studied the safety and preclinical efficacy of using these enzymes to remove A antigen from human donor lungs using ex vivo lung perfusion.